Dyne therapeutics inc
WebApr 11, 2024 · Dyne Therapeutics Stock Performance. NASDAQ DYN opened at $8.82 on Tuesday. The stock has a market cap of $496.90 million, a price-to-earnings ratio of … WebDyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.The company's therapies deliver nucleic acids and other molecules to skeletal, …
Dyne therapeutics inc
Did you know?
WebInteldyne Salaries trends. 68 salaries for 5 jobs at Inteldyne in Sterling, VA. Salaries posted anonymously by Inteldyne employees in Sterling, VA. WebApr 5, 2024 · Dyne Therapeutics Inc's score of 87 means it scores higher than 87% of stocks in the industry. Dyne Therapeutics Inc also received an overall rating of 71, putting it above 71% of all stocks. Biotechnology is ranked 40 out of the 148 industries. DYN has an Overall Score of 71. Find out what this means to you and get the rest of the rankings on …
WebMar 23, 2024 · About Dyne Therapeutics. Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases. With its proprietary FORCE™ platform, Dyne is developing modern oligonucleotide therapeutics that are designed to overcome … WebDyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.The company's therapies deliver nucleic acids and other molecules to skeletal, cardiac and smooth muscle with unprecedented precision, enabling patients to restore muscle strength and transform their lives.
WebDyne Therapeutics Inc Working Capital Per Revenue on the trailing twelve month basis from the forth quarter 2024 to forth quarter 2024, Trends and Ranking, Fundamental Ratios - CSIMarket Company Name, Ticker, Suppliers, else.. WebCompany profile page for Dyne Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information
WebJan 8, 2024 · Patent number: 11518816. Abstract: Aspects of the disclosure relate to complexes comprising a muscle-targeting agent covalently linked to a molecular payload. In some embodiments, the muscle-targeting agent specifically binds to an internalizing cell surface receptor on muscle cells. In some embodiments, the molecular payload inhibits ...
WebApr 7, 2024 · Dyne Therapeutics Inc is a bio-technology company focused on providing therapeutics for patients with genetically driven diseases. The company is developing … notlandung a380 heuteWebMoody's. Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as … notlacific islander americansWebApr 11, 2024 · Dyne Therapeutics Trading Down 6.0 %. DYN stock opened at $8.82 on Tuesday. The firm has a 50 day moving average of $12.59 and a 200-day moving … how to share zebra printer over networkWebNov 2, 2024 · Dyne Therapeutics Announces First Patient Dosed in Phase 1/2 DELIVER Clinical Trial of DYNE-251 for the Treatment of Duchenne Muscular Dystrophy. August … how to share youtube music accountWebGet in touch. 45190 Prologis Plaza, Suite 165. Dulles , VA 20166USA. 703.478.6009 how to share youtube video with thumbnailWebFind the latest Dyne Therapeutics, Inc. (DYN) stock quote, history, news and other vital information to help you with your stock trading and investing. notlandung auf mallorcaWebMar 14, 2024 · 天眼查为您提供Dyne Therapeutics Inc.的企业信息查询服务，查询Dyne Therapeutics Inc.工商注册信息、公司电话、公司地址、公司邮箱网址、公司经营风险、公司发展状况、公司财务状况、公司股东法人高管、商标、融资、专利、法律诉讼等Dyne Therapeutics Inc.企业信用信息，想了解Dyne Therapeutics Inc.怎么样，就 ... notlandung flugzeug themse